Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q4 2024 Earnings Conference Call March 20, 2025 5:00 PM ET
Company Participants
Deb Hart – Head, IR
Kevin Herde – EVP and CFO
Trey Martin – CEO
Conference Call Participants
Matt Stanton – Jeffries
Doug Schenkel – Wolfe Research
Matt Larew – William Blair
Ricki Levitus – Guggenheim
Tejas Savant – Morgan Stanley
Dan Arias – Stifel
Catherine Schulte – Baird
Matt Sykes – Goldman Sachs
Brandon Coulliard – Wells Fargo
Anna Snopkowski – KeyBanc Capital Markets
Operator
Greetings. Welcome to Maravai LifeSciences Fourth Quarter 2024 Results Earnings Call. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.
It is now my pleasure to introduce Deb Hart, Head of Investor Relations. Thank you. You may begin.
Deb Hart
Good afternoon, everyone. Thanks for joining us on our fourth quarter and year-end 2024 earnings call. The slides accompanying today’s call are posted on our website and available at investors.maravai.com.
As you can see from the agenda on Slide 2, Trey Martin, Chief Executive Officer, and Kevin Herde, Chief Financial Officer, are joining me today. Following their prepared remarks, we’ll open the call for the question and answer session.
We remind you that management will make forward-looking statements and refer to GAAP and non-GAAP financial measures during today’s call. It is possible that actual results could differ from management’s expectations. We refer you to Slide 3 for more details on forward-looking statements and our use of non-GAAP financial measures. Our press release provides reconciliations to the most directly comparable GAAP measures, and we also provide a reconciliation of non-GAAP financial information on our investor website. Please also refer to Maravai’s SEC filings for additional information on the risks and uncertainties
